Iron Absorption From Iron Fortified Extruded Rice Co-fortified With Various Solubilizing Agents

Sponsor
Swiss Federal Institute of Technology (Other)
Overall Status
Unknown status
CT.gov ID
NCT03703739
Collaborator
(none)
22
1
7
2
11.2

Study Details

Study Description

Brief Summary

Food fortification is regarded as a safe and cost-effective approach to counteract and prevent iron deficiency. Rice is a staple food for millions of people living in regions where iron-deficiency anaemia is a significant public health problem. Therefore, rice may be a promising fortification vehicle. Ferric pyrophosphate (FePP) is an acceptable iron compound for rice fortification, due to its white colour and low reactivity with the rice matrix. However, iron from FePP generally has a low bioavailability. To increase the low iron bioavailability of FePP in fortified rice, ligands acting as solubilizing agents have been suggested, such as citric acid/trisodium citrate (CA/TSC), ethylenediaminetetraacetic acid (EDTA) and sodium pyrophosphate (NaPP).

It is however unclear to which extent CA/TSC would enhance iron bioavailability in presence of phytic acid, a common inhibitor of iron absorption found in whole grains and legumes. Zinc oxide reduces iron bioavailability from FePP with and without CA/TSC, in contrast to Zinc sulphate. It is however unclear if this decrease would be also expected in presence of EDTA as solubilizing agent. Further, NaPP has been suggested as a solubilizing agent, enhancing the bioavailability from FePP in bouillon cubes. This study aim to test its effect in rice. Meals containing a high (bean sauce) and low (mixed vegetable) phytic acid level sauce will be used to simulated varying dietary backgrounds, allowing to answer the question which solubilizing agent is viable in enhancing iron bioavailability.

Condition or Disease Intervention/Treatment Phase
  • Dietary Supplement: Reference meal 1
  • Dietary Supplement: Reference 2
  • Dietary Supplement: Test meal A
  • Dietary Supplement: Test meal B
  • Dietary Supplement: Test meal C
  • Dietary Supplement: Test meal D
  • Dietary Supplement: Test meal E
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
22 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Single (Participant)
Primary Purpose:
Prevention
Official Title:
Effect of Solubilizing Agents on Iron Absorption From Iron Fortified Rice in Young Women
Actual Study Start Date :
Oct 2, 2018
Anticipated Primary Completion Date :
Dec 1, 2018
Anticipated Study Completion Date :
Dec 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Reference meal 1

50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with mixed vegetable Sauce.

Dietary Supplement: Reference meal 1
1 ml Ferrous sulfate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g mixed vegetable Sauce and 300 ml nanopure water

Active Comparator: Reference 2

50 g of Commercial Rice (Jasmin Rice) (dry weight) was cooked and 4 mg iron from Ferrous sulfate was added Prior to give to participants. Rice meal consumed with bean sauce.

Dietary Supplement: Reference 2
1 ml Ferrous sulphate solution (4mgFe/ml) was added in cooked comercial Rice Prior to served to participant. The meal served with 30 g bean Sauce and 300 ml nanopure water

Experimental: Test meal A

Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice cofortified with zinc oxide and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

Dietary Supplement: Test meal A
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc oxide and ethylenediaminetetraacetic acid

Experimental: Test meal B

Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate and ethylenediaminetetraacetic acid (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

Dietary Supplement: Test meal B
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and ethylenediaminetetraacetic acid

Experimental: Test meal C

Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

Dietary Supplement: Test meal C
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.

Experimental: Test meal D

Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfafe and sodium pyrophosphate (mixing ratio 100:1), Rice meal consumed with mixed vegetable Sauce.

Dietary Supplement: Test meal D
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g vegetable Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate and sodium pyrophosphate.

Experimental: Test meal E

Commercial Rice (Jasmin Rice) was mixed with iron fortified extuded rice co-fortified with zinc sulfate, citric acid and trisodium citrate (mixing ratio 100:1), Rice meal consumed with bean Sauce.

Dietary Supplement: Test meal E
Fortified extruded Rice was mixed with Commercial Rice (mixing Ratio: 1:100) The meal served with 30 g bean Sauce and 300 ml nanopure water. ** composition of extruded Rice: Ferric pyrophosphate, zinc sulfate, citric acid and trisodium Citrate.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in the isotopic ratio of iron in blood at week 2 [baseline, 2 weeks]

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

  2. Change from week 2 in the isotopic ratio of iron in blood at week 4 [2 weeks, 4 weeks]

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

  3. Change from week 4 in the isotopic ratio of iron in blood at week 6 [4 weeks, 6 weeks]

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

  4. Change from week 6 in the isotopic ratio of iron in blood at week 8 [6 weeks, 8 weeks]

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

  5. Change from week 8 in the isotopic ratio of iron in blood at week 10 [8 weeks, 10 weeks]

    The change in the isotopic ratio of iron will be measured after the administration of test meal including iron isotopes.

Secondary Outcome Measures

  1. Haemoglobin [2, 4,6,8 and 10 weeks]

    Haemoglobin of each timepoint

  2. Plasma Ferritin [2, 4, 6, 8 and 10 weeks]

    Plasma Ferritin of each timepoint

  3. Inflammation Marker [2, 4, 6, 8 and 10 weeks]

    Plasma Ferririn of each timepoint

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Female, 18 to 40 years old

  • Normal body Mass Index (18.5 - 25 kg/m2)

  • Body weight ≤ 65 kg

  • Signed informed consent

Exclusion Criteria:
  • Pregnancy (assessed by self-declaration)

  • Lactating up to 6 weeks before study initiation

  • Anaemia (Hb < 12.0 g/dL)

  • Elevate CRP (>5.0 mg/L)

  • Any metabolic, gastrointestinal kidney or chronic disease such as diabetes, hepatitis, hypertension, cancer or cardiovascular diseases (according to the participants own statement)

  • Continuous/long-term use of medication during the whole study (except for contraceptives)

  • Consumption of mineral and vitamin supplements within 2 weeks prior to 1st meal administration

  • Blood transfusion, blood donation or significant blood loss (accident, surgery) over the past 4 months

  • Earlier participation in a study using Fe stable isotopes or participation in any clinical study within the last 30 days

  • Participant who cannot be expected to comply with study protocol (e.g. not available on certain study appointments)

  • Smokers (> 1 cigarette per week)

  • Difficulties with blood sampling

  • Male gender

  • Do not understand English

Contacts and Locations

Locations

Site City State Country Postal Code
1 Human Nutrition Laboratory, ETH Zurich Zürich Switzerland 8092

Sponsors and Collaborators

  • Swiss Federal Institute of Technology

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Swiss Federal Institute of Technology
ClinicalTrials.gov Identifier:
NCT03703739
Other Study ID Numbers:
  • Iron_RiceSolubilizing
First Posted:
Oct 12, 2018
Last Update Posted:
Oct 12, 2018
Last Verified:
Oct 1, 2018
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Swiss Federal Institute of Technology
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 12, 2018